{
  "name": "Moberg Pharma",
  "slug": "moberg-pharma",
  "description": "Statiskt källarkiv med kurshistorik, finansiella rapporter och regulatoriska dokument. För nordiska bolag används Nasdaq Nordic primärt och MFN endast för saknade rapportperioder.",
  "status": "complete",
  "updated_at": "2026-08-07T05:44:00Z",
  "nasdaq_status": "retrieved",
  "latest_market": "2026-08-06: stängning 9.51, volym 41414",
  "mfn_status": "resolved_no_reports",
  "mfn_count": 0,
  "nasdaq_reports_status": "retrieved",
  "reports": {
    "available": true,
    "url": "/company/moberg-pharma/reports",
    "count": 16,
    "nasdaq_count": 16,
    "mfn_fallback_count": 0,
    "items": [
      {
        "report_key": "2026:q1",
        "period_label": "2026 Q1",
        "date": "2026-05-12",
        "title": "Kvartalsrapport Q1 2026",
        "original_title": "Delårsrapport januari - mars 2026",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bd8bfd1621c14ce7d37a887abba216820&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2026,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
            "title": "Kvartalsrapport Q1 2026",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a33ca736461d70a771af7251d5d201e1f",
            "date": "2026-05-12",
            "period": "2026-q1",
            "form_type": "interim-report",
            "report_key": "2026:q1",
            "filename": "05111212.pdf",
            "text_chars": 40158,
            "sha256": "eec9efb8ab54a89d5132de2b301defe81e5efcbe56128a634b54614089bd85f6",
            "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
            "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
            "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
                "chars": 40158
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:annual",
        "period_label": "2025 Årsredovisning",
        "date": "2026-04-17",
        "title": "Årsredovisning 2025",
        "original_title": "Moberg Pharmas årsredovisning för räkenskapsåret 2025 offentliggjord",
        "category": "Övrig information som ska lämnas enligt börsens regler",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b46d473bd96ac88a93171ea16ac123e5d&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2025,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2025",
            "title": "Årsredovisning 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a0917f6991d6c3be300cd92421349d4be",
            "date": "2026-04-17",
            "period": "2025-annual",
            "form_type": "annual-report",
            "report_key": "2025:annual",
            "filename": "04169804.pdf",
            "text_chars": 236130,
            "sha256": "40d505db6959517a590cdf9507121369e549bd7c7964ac2a2613ac4f99c0d832",
            "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2025",
            "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2025",
            "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
                "chars": 177675
              },
              {
                "number": 2,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
                "chars": 58453
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q4",
        "period_label": "2025 Q4",
        "date": "2026-02-17",
        "title": "Kvartalsrapport Q4 2025",
        "original_title": "Moberg Pharma bokslutskommuniké 2025",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b40c3e0001360ece8761995aaa378e08a&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2025,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
            "title": "Kvartalsrapport Q4 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/acc11051b4d2bceb57dbf5b2a9ba1ff69",
            "date": "2026-02-17",
            "period": "2025-q4",
            "form_type": "year-end-report",
            "report_key": "2025:q4",
            "filename": "02161823.pdf",
            "text_chars": 42700,
            "sha256": "5669c83cdc53f4b22974c53dbab55ceb39718ea34c3a741e04baba6cbc97af06",
            "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
            "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
            "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
                "chars": 42700
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q3",
        "period_label": "2025 Q3",
        "date": "2025-11-11",
        "title": "Kvartalsrapport Q3 2025",
        "original_title": "Moberg Pharmas delårsrapport januari - september 2025",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b25c4bde78c49d222f408727bfd59e045&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
            "title": "Kvartalsrapport Q3 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a178f416752247c2e0c187254b6798490",
            "date": "2025-11-11",
            "period": "2025-q3",
            "form_type": "interim-report",
            "report_key": "2025:q3",
            "filename": "11107927.pdf",
            "text_chars": 46645,
            "sha256": "7e4e9819200e47890c19f17e84f6d0d6b47e7a5f6eccada7010068b139befc67",
            "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
            "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
            "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
                "chars": 46645
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q2",
        "period_label": "2025 Q2",
        "date": "2025-08-12",
        "title": "Kvartalsrapport Q2 2025",
        "original_title": "Delårsrapport januari - juni 2025",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b80d2e318ec7fd7fed0b95625c47856fa&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
            "title": "Kvartalsrapport Q2 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ac241e37e905facaca03e613f2fe29308",
            "date": "2025-08-12",
            "period": "2025-q2",
            "form_type": "interim-report",
            "report_key": "2025:q2",
            "filename": "08119244.pdf",
            "text_chars": 42376,
            "sha256": "73b37b43414bf55370ccc87264a3b665f50ee25abe61b05a9700794d7fffcce8",
            "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
            "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
            "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
                "chars": 42376
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q1",
        "period_label": "2025 Q1",
        "date": "2025-05-13",
        "title": "Kvartalsrapport Q1 2025",
        "original_title": "Moberg Pharmas delårsrapport januari - mars 2025",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bd6c84ce0c3c9ee34fdd221209aed6946&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
            "title": "Kvartalsrapport Q1 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a53a15141ad43e9c9a9b3d1313756c139",
            "date": "2025-05-13",
            "period": "2025-q1",
            "form_type": "interim-report",
            "report_key": "2025:q1",
            "filename": "05120994.pdf",
            "text_chars": 40066,
            "sha256": "5f81368e9e8cb83ef48f8c90fb48c0b3bb319547a31c40892f0a3554a031f960",
            "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
            "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
            "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
                "chars": 40066
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:annual",
        "period_label": "2024 Årsredovisning",
        "date": "2025-04-11",
        "title": "Årsredovisning 2024",
        "original_title": "Moberg Pharmas årsredovisning för räkenskapsåret 2024 offentliggjord",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b0436a81616efdca7b2ca3db153e05822&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2024,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2024",
            "title": "Årsredovisning 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a49c5138d6bfe58b2666822812b59f4cc",
            "date": "2025-04-11",
            "period": "2024-annual",
            "form_type": "annual-report",
            "report_key": "2024:annual",
            "filename": "04105917.pdf",
            "text_chars": 237739,
            "sha256": "952c67c09b3a817cc9600b274370a0720b40aed9751b45fc8f8343d41f6b3342",
            "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2024",
            "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2024",
            "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
                "chars": 179289
              },
              {
                "number": 2,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
                "chars": 58448
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q4",
        "period_label": "2024 Q4",
        "date": "2025-02-11",
        "title": "Kvartalsrapport Q4 2024",
        "original_title": "Moberg Pharmas bokslutskommuniké 2024",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=baf90e9b2c925e7baab310cdfa38ccc32&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2024,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
            "title": "Kvartalsrapport Q4 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a49d7fcb0776498422b629a0d11658605",
            "date": "2025-02-11",
            "period": "2024-q4",
            "form_type": "year-end-report",
            "report_key": "2024:q4",
            "filename": "02104805.pdf",
            "text_chars": 45172,
            "sha256": "23d6c80cd1b24799649963b2004f5e86f8e0fc2580591994c7a4dffaa2b55c4e",
            "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
            "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
            "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
                "chars": 45172
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q3",
        "period_label": "2024 Q3",
        "date": "2024-11-12",
        "title": "Kvartalsrapport Q3 2024",
        "original_title": "Moberg Pharmas delårsrapport januari - september 2024",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=be716cc5324ebea79369e3fdfdcaa8de5&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
            "title": "Kvartalsrapport Q3 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a80f1a2120999595c11908852743cde4c",
            "date": "2024-11-12",
            "period": "2024-q3",
            "form_type": "interim-report",
            "report_key": "2024:q3",
            "filename": "11115568.pdf",
            "text_chars": 46994,
            "sha256": "605be590ea4094ba24a78272e651a3962e214d36b253761bc65ef6417ce9aaa9",
            "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
            "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
            "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
                "chars": 46994
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q2",
        "period_label": "2024 Q2",
        "date": "2024-08-13",
        "title": "Kvartalsrapport Q2 2024",
        "original_title": "Moberg Pharmas delårsrapport januari - juni 2024",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bc9580d8f46241b87364a8fc36a4fd081&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
            "title": "Kvartalsrapport Q2 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ad8c9de2d124edc7dc67a43c48400493d",
            "date": "2024-08-13",
            "period": "2024-q2",
            "form_type": "interim-report",
            "report_key": "2024:q2",
            "filename": "08124063.pdf",
            "text_chars": 42791,
            "sha256": "4434f8270a18cbbdc489caf4ade80d572d66aceaf88d6372284070856e0f8647",
            "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
            "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
            "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
                "chars": 42791
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q1",
        "period_label": "2024 Q1",
        "date": "2024-05-07",
        "title": "Kvartalsrapport Q1 2024",
        "original_title": "Moberg Pharmas delårsrapport januari - mars 2024",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=ba510d2000cd66d39f964a1ac53f4cf53&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
            "title": "Kvartalsrapport Q1 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ac4858f04198212185bf639dd1ab14e12",
            "date": "2024-05-07",
            "period": "2024-q1",
            "form_type": "interim-report",
            "report_key": "2024:q1",
            "filename": "05064576.pdf",
            "text_chars": 39027,
            "sha256": "191531dfa0611531ab7b62a7617f4498806249ce5b012d7f92d420b336202034",
            "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
            "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
            "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
                "chars": 39027
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:annual",
        "period_label": "2023 Årsredovisning",
        "date": "2024-04-12",
        "title": "Årsredovisning 2023",
        "original_title": "Moberg Pharmas årsredovisning för räkenskapsåret 2023 offentliggjord",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b96d30a7261becb4fa9bce4714dffd517&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2023,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2023",
            "title": "Årsredovisning 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/aa992845d56c11ed656a9e84a2417670a",
            "date": "2024-04-12",
            "period": "2023-annual",
            "form_type": "annual-report",
            "report_key": "2023:annual",
            "filename": "04110439.pdf",
            "text_chars": 236217,
            "sha256": "35d5862def1400adb3c8886f003cc0bdadb010b6eb94798b112c55125e05e461",
            "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2023",
            "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2023",
            "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
                "chars": 178691
              },
              {
                "number": 2,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
                "chars": 57524
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q4",
        "period_label": "2023 Q4",
        "date": "2024-02-13",
        "title": "Kvartalsrapport Q4 2023",
        "original_title": "Bokslutskommuniké 2023",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bffbd5de14e3656e097b40015e2307764&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2023,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
            "title": "Kvartalsrapport Q4 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a18b0f28e1473af0169520a46183acb6d",
            "date": "2024-02-13",
            "period": "2023-q4",
            "form_type": "year-end-report",
            "report_key": "2023:q4",
            "filename": "02126814.pdf",
            "text_chars": 41832,
            "sha256": "2ea9b564a8142e5b48190c78bd69c156624a7f2a277a8562b2733aa12446a2e4",
            "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
            "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
            "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
                "chars": 41832
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q3",
        "period_label": "2023 Q3",
        "date": "2023-11-07",
        "title": "Kvartalsrapport Q3 2023",
        "original_title": "Moberg Pharmas delårsrapport januari - september 2023",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b20e28bb9d5e601dcc82671e76432a626&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
            "title": "Kvartalsrapport Q3 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a13541e6792fa90aacea1c7c49dcc5d72",
            "date": "2023-11-07",
            "period": "2023-q3",
            "form_type": "interim-report",
            "report_key": "2023:q3",
            "filename": "11069198.pdf",
            "text_chars": 44269,
            "sha256": "f5e96900782a0e062251b8a70fa43050da7f0e4490216e0158a22d679d1f8077",
            "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
            "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
            "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
                "chars": 44269
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q2",
        "period_label": "2023 Q2",
        "date": "2023-08-03",
        "title": "Kvartalsrapport Q2 2023",
        "original_title": "Moberg Pharmas delårsrapport januari - juni 2023",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b1082d35e4d8460c273e1caea48cac238&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
            "title": "Kvartalsrapport Q2 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a3ace2efddca7c5f5f301e7a02b74dff4",
            "date": "2023-08-03",
            "period": "2023-q2",
            "form_type": "interim-report",
            "report_key": "2023:q2",
            "filename": "08021298.pdf",
            "text_chars": 40267,
            "sha256": "4b01c41ebadd918f34d97d01cf82049932396e2eadaa2fc1a503995ff3c2f3d0",
            "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
            "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
            "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
                "chars": 40267
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q1",
        "period_label": "2023 Q1",
        "date": "2023-05-09",
        "title": "Kvartalsrapport Q1 2023",
        "original_title": "Moberg Pharmas delårsrapport januari - mars 2023",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b5d0b7483d8b050ed5339da2cc91f932c&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
            "title": "Kvartalsrapport Q1 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a48aae1f357bb375199230e6b5ed706ad",
            "date": "2023-05-09",
            "period": "2023-q1",
            "form_type": "interim-report",
            "report_key": "2023:q1",
            "filename": "05084027.pdf",
            "text_chars": 32537,
            "sha256": "46e2f3a7c3f65a498963bae953eda6477c4a41b7a28e0175c548cbe4dc5acc7a",
            "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
            "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
            "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
                "chars": 32537
              }
            ]
          }
        ],
        "alternatives": []
      }
    ]
  },
  "report_count": 16,
  "nasdaq_report_count": 16,
  "mfn_fallback_count": 0,
  "sec_status": "skipped",
  "sec_count": 0,
  "fi_status": "retrieved",
  "fi_summary": {
    "company": "Moberg Pharma",
    "identity": {
      "issuer": "Moberg Pharma AB (publ)",
      "lei": "549300XFXK7DVGDRP410",
      "source": "FI aggregerade blankningspositioner",
      "row_count": 13,
      "score": 118.0,
      "status": "resolved",
      "requested_company": "Moberg Pharma",
      "query": "Moberg Pharma AB (publ)",
      "candidate_count": 346
    },
    "period": {
      "from": "2024-08-07",
      "to": "2026-08-07",
      "years": 2
    },
    "generated_at": "2026-08-07T05:44:00Z",
    "insider": {
      "transactions": 23,
      "all_export_rows": 23,
      "acquisitions": 12,
      "disposals": 4,
      "other": 7,
      "acquisition_value_sek": 295294.71,
      "disposal_value_sek": 1248548.54,
      "characters": {
        "Avyttring": 4,
        "Förvärv": 12,
        "Tilldelning": 7
      }
    },
    "short_selling": {
      "aggregate_percent": 0.83,
      "current_public_positions": 1,
      "historical_changes": 8,
      "current_position_sum_over_0_5": 0.83
    },
    "sources": {
      "insider_register": "https://www.fi.se/sv/vara-register/insynsregistret/",
      "short_register": "https://www.fi.se/sv/vara-register/blankningsregistret/"
    }
  },
  "warnings": [
    "MFN fallback: resolved_no_reports"
  ],
  "source_identity": {
    "nasdaq_reports": {
      "slug": "",
      "instrument_id": "TX895320",
      "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/mob?id=TX895320"
    },
    "mfn": {
      "status": "resolved",
      "company_name": "Moberg Pharma",
      "expected_name": "Moberg Pharma",
      "match_score": 100.0,
      "slug": "moberg-pharma",
      "url": "https://mfn.se/all/a/moberg-pharma",
      "metadata": {
        "country": "Sverige",
        "list": "Small Cap Stockholm",
        "sector": "Hälsovård",
        "industry": "Bioteknik",
        "website": "https://mb.cision.com/Main/1662/4365607/4159851.pdf"
      },
      "ticker_candidates": [],
      "attempts": []
    },
    "sec": null,
    "nasdaq": {
      "instrument_id": "TX895320",
      "asset_class": "SHARES",
      "isin": "SE0020353928",
      "symbol": "MOB",
      "company": "Moberg Pharma",
      "market": null,
      "last_sale_price": "SEK 9.51",
      "time_as_of": "2026-08-06"
    },
    "finansinspektionen": {
      "issuer": "Moberg Pharma AB (publ)",
      "lei": "549300XFXK7DVGDRP410",
      "source": "FI aggregerade blankningspositioner",
      "row_count": 13,
      "score": 118.0,
      "status": "resolved",
      "requested_company": "Moberg Pharma",
      "query": "Moberg Pharma AB (publ)",
      "candidate_count": 346
    }
  },
  "documents": [
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
      "title": "Kvartalsrapport Q1 2026",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a33ca736461d70a771af7251d5d201e1f",
      "date": "2026-05-12",
      "period": "2026-q1",
      "form_type": "interim-report",
      "report_key": "2026:q1",
      "filename": "05111212.pdf",
      "text_chars": 40158,
      "sha256": "eec9efb8ab54a89d5132de2b301defe81e5efcbe56128a634b54614089bd85f6",
      "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
      "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
          "chars": 40158
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2025",
      "title": "Årsredovisning 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a0917f6991d6c3be300cd92421349d4be",
      "date": "2026-04-17",
      "period": "2025-annual",
      "form_type": "annual-report",
      "report_key": "2025:annual",
      "filename": "04169804.pdf",
      "text_chars": 236130,
      "sha256": "40d505db6959517a590cdf9507121369e549bd7c7964ac2a2613ac4f99c0d832",
      "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2025",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2025",
      "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
          "chars": 177675
        },
        {
          "number": 2,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
          "chars": 58453
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
      "title": "Kvartalsrapport Q4 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/acc11051b4d2bceb57dbf5b2a9ba1ff69",
      "date": "2026-02-17",
      "period": "2025-q4",
      "form_type": "year-end-report",
      "report_key": "2025:q4",
      "filename": "02161823.pdf",
      "text_chars": 42700,
      "sha256": "5669c83cdc53f4b22974c53dbab55ceb39718ea34c3a741e04baba6cbc97af06",
      "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
      "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
          "chars": 42700
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
      "title": "Kvartalsrapport Q3 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a178f416752247c2e0c187254b6798490",
      "date": "2025-11-11",
      "period": "2025-q3",
      "form_type": "interim-report",
      "report_key": "2025:q3",
      "filename": "11107927.pdf",
      "text_chars": 46645,
      "sha256": "7e4e9819200e47890c19f17e84f6d0d6b47e7a5f6eccada7010068b139befc67",
      "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
      "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
          "chars": 46645
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
      "title": "Kvartalsrapport Q2 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ac241e37e905facaca03e613f2fe29308",
      "date": "2025-08-12",
      "period": "2025-q2",
      "form_type": "interim-report",
      "report_key": "2025:q2",
      "filename": "08119244.pdf",
      "text_chars": 42376,
      "sha256": "73b37b43414bf55370ccc87264a3b665f50ee25abe61b05a9700794d7fffcce8",
      "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
      "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
          "chars": 42376
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
      "title": "Kvartalsrapport Q1 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a53a15141ad43e9c9a9b3d1313756c139",
      "date": "2025-05-13",
      "period": "2025-q1",
      "form_type": "interim-report",
      "report_key": "2025:q1",
      "filename": "05120994.pdf",
      "text_chars": 40066,
      "sha256": "5f81368e9e8cb83ef48f8c90fb48c0b3bb319547a31c40892f0a3554a031f960",
      "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
      "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
          "chars": 40066
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2024",
      "title": "Årsredovisning 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a49c5138d6bfe58b2666822812b59f4cc",
      "date": "2025-04-11",
      "period": "2024-annual",
      "form_type": "annual-report",
      "report_key": "2024:annual",
      "filename": "04105917.pdf",
      "text_chars": 237739,
      "sha256": "952c67c09b3a817cc9600b274370a0720b40aed9751b45fc8f8343d41f6b3342",
      "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2024",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2024",
      "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
          "chars": 179289
        },
        {
          "number": 2,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
          "chars": 58448
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
      "title": "Kvartalsrapport Q4 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a49d7fcb0776498422b629a0d11658605",
      "date": "2025-02-11",
      "period": "2024-q4",
      "form_type": "year-end-report",
      "report_key": "2024:q4",
      "filename": "02104805.pdf",
      "text_chars": 45172,
      "sha256": "23d6c80cd1b24799649963b2004f5e86f8e0fc2580591994c7a4dffaa2b55c4e",
      "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
      "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
          "chars": 45172
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
      "title": "Kvartalsrapport Q3 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a80f1a2120999595c11908852743cde4c",
      "date": "2024-11-12",
      "period": "2024-q3",
      "form_type": "interim-report",
      "report_key": "2024:q3",
      "filename": "11115568.pdf",
      "text_chars": 46994,
      "sha256": "605be590ea4094ba24a78272e651a3962e214d36b253761bc65ef6417ce9aaa9",
      "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
      "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
          "chars": 46994
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
      "title": "Kvartalsrapport Q2 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ad8c9de2d124edc7dc67a43c48400493d",
      "date": "2024-08-13",
      "period": "2024-q2",
      "form_type": "interim-report",
      "report_key": "2024:q2",
      "filename": "08124063.pdf",
      "text_chars": 42791,
      "sha256": "4434f8270a18cbbdc489caf4ade80d572d66aceaf88d6372284070856e0f8647",
      "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
      "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
          "chars": 42791
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
      "title": "Kvartalsrapport Q1 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ac4858f04198212185bf639dd1ab14e12",
      "date": "2024-05-07",
      "period": "2024-q1",
      "form_type": "interim-report",
      "report_key": "2024:q1",
      "filename": "05064576.pdf",
      "text_chars": 39027,
      "sha256": "191531dfa0611531ab7b62a7617f4498806249ce5b012d7f92d420b336202034",
      "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
      "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
          "chars": 39027
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2023",
      "title": "Årsredovisning 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/aa992845d56c11ed656a9e84a2417670a",
      "date": "2024-04-12",
      "period": "2023-annual",
      "form_type": "annual-report",
      "report_key": "2023:annual",
      "filename": "04110439.pdf",
      "text_chars": 236217,
      "sha256": "35d5862def1400adb3c8886f003cc0bdadb010b6eb94798b112c55125e05e461",
      "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2023",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2023",
      "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
          "chars": 178691
        },
        {
          "number": 2,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
          "chars": 57524
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
      "title": "Kvartalsrapport Q4 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a18b0f28e1473af0169520a46183acb6d",
      "date": "2024-02-13",
      "period": "2023-q4",
      "form_type": "year-end-report",
      "report_key": "2023:q4",
      "filename": "02126814.pdf",
      "text_chars": 41832,
      "sha256": "2ea9b564a8142e5b48190c78bd69c156624a7f2a277a8562b2733aa12446a2e4",
      "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
      "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
          "chars": 41832
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
      "title": "Kvartalsrapport Q3 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a13541e6792fa90aacea1c7c49dcc5d72",
      "date": "2023-11-07",
      "period": "2023-q3",
      "form_type": "interim-report",
      "report_key": "2023:q3",
      "filename": "11069198.pdf",
      "text_chars": 44269,
      "sha256": "f5e96900782a0e062251b8a70fa43050da7f0e4490216e0158a22d679d1f8077",
      "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
      "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
          "chars": 44269
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
      "title": "Kvartalsrapport Q2 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a3ace2efddca7c5f5f301e7a02b74dff4",
      "date": "2023-08-03",
      "period": "2023-q2",
      "form_type": "interim-report",
      "report_key": "2023:q2",
      "filename": "08021298.pdf",
      "text_chars": 40267,
      "sha256": "4b01c41ebadd918f34d97d01cf82049932396e2eadaa2fc1a503995ff3c2f3d0",
      "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
      "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
          "chars": 40267
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
      "title": "Kvartalsrapport Q1 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a48aae1f357bb375199230e6b5ed706ad",
      "date": "2023-05-09",
      "period": "2023-q1",
      "form_type": "interim-report",
      "report_key": "2023:q1",
      "filename": "05084027.pdf",
      "text_chars": 32537,
      "sha256": "46e2f3a7c3f65a498963bae953eda6477c4a41b7a28e0175c548cbe4dc5acc7a",
      "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
      "txt_url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/moberg-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
          "chars": 32537
        }
      ]
    },
    {
      "doc_id": "mfn-mfn-bolagssida-och-bolagsmetadata",
      "title": "MFN bolagssida och bolagsmetadata",
      "source": "MFN",
      "source_class": "mfn",
      "source_url": "https://mfn.se/all/a/moberg-pharma",
      "date": null,
      "period": null,
      "form_type": "company-page",
      "report_key": null,
      "filename": "company.txt",
      "text_chars": 13287,
      "sha256": "85625de7b40075ccacaa1ad9f090d31ca0fd6c545868096c9a9aa8b9fb306426",
      "url": "/company/moberg-pharma/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
      "txt_url": "/company/moberg-pharma/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/moberg-pharma/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/moberg-pharma/documents/mfn-mfn-bolagssida-och-bolagsmetadata/part-001.html",
          "chars": 13287
        }
      ]
    }
  ],
  "market_files": [
    {
      "label": "Nasdaq kurshistorik CSV",
      "url": "/company/moberg-pharma/market/history.csv",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/market/history.csv"
    },
    {
      "label": "Nasdaq kurshistorik JSON",
      "url": "/company/moberg-pharma/market/history.json",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/market/history.json"
    },
    {
      "label": "Nasdaq manifest JSON",
      "url": "/company/moberg-pharma/market/manifest.json",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/market/manifest.json"
    },
    {
      "label": "Nasdaq instrumentidentitet JSON",
      "url": "/company/moberg-pharma/market/instrument.json",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/market/instrument.json"
    },
    {
      "label": "MFN manifest JSON",
      "url": "/company/moberg-pharma/market/mfn-manifest.json",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/market/mfn-manifest.json"
    },
    {
      "label": "Nasdaq rapportmanifest JSON",
      "url": "/company/moberg-pharma/market/nasdaq-reports-manifest.json",
      "absolute_url": "https://spela.port0.org/company/moberg-pharma/market/nasdaq-reports-manifest.json"
    }
  ],
  "sec_facts": {
    "status": "missing",
    "metrics": []
  },
  "morningstar": {
    "configured": false,
    "status": "inte hämtad",
    "captured_at": null,
    "view_count": 0,
    "url": "/company/moberg-pharma/morningstar"
  },
  "finansinspektionen": {
    "available": true,
    "status": "retrieved",
    "url": "/company/moberg-pharma/finansinspektionen",
    "transaction_count": 23,
    "aggregate_short_percent": 0.83,
    "files": [
      {
        "filename": "summary.json",
        "label": "Sammanfattning JSON",
        "url": "summary.json"
      },
      {
        "filename": "insider-transactions.csv",
        "label": "Insynstransaktioner CSV",
        "url": "insider-transactions.csv"
      },
      {
        "filename": "insider-transactions.json",
        "label": "Insynstransaktioner JSON",
        "url": "insider-transactions.json"
      },
      {
        "filename": "short-current.json",
        "label": "Aktuella blankningspositioner JSON",
        "url": "short-current.json"
      },
      {
        "filename": "short-history.json",
        "label": "Historiska blankningspositioner JSON",
        "url": "short-history.json"
      },
      {
        "filename": "short-aggregate.json",
        "label": "Aggregerad blankning JSON",
        "url": "short-aggregate.json"
      },
      {
        "filename": "manifest.json",
        "label": "Hämtningsmanifest JSON",
        "url": "manifest.json"
      }
    ]
  },
  "llms_url": "/company/moberg-pharma/llms.txt",
  "json_url": "/company/moberg-pharma/company.json",
  "document_index_url": "/company/moberg-pharma/documents.json",
  "absolute_url": "https://spela.port0.org/company/moberg-pharma"
}